Pure Global
PACTR201810815694251

A Randomised Controlled Trial Comparing Topical Glycerol versus Narrow Band Ultraviolet Light B in Atopic Dermatitis: A Clinical and Bacteriological Evaluation

Cairo University·Not Applicable·Pan Africa Clinical Trials Registry·otherCompleted
Study focus
Disease/Condition
Skin and Connective Tissue Diseases
Intervention type
other
Sponsor & location
Primary sponsor
Cairo University
Funder
Self funded by investigator
Location
Egypt
Timeline & enrollment
Phase
Not Applicable
Start date
Jan 01, 1900
End date
Jan 01, 1900
Summary

Background: Atopic dermatitis (AD) is a chronic allergic disorder whose treatment is still a challenge. The staphylococcal skin load has been previously shown to aggravate AD. Narrow band ultraviolet B (NB-UVB) and glycerol in low concentration (20-40%) are established therapies for AD. Narrow band-UVB has been clinically proven to have antimicrobial actions and high concentration glycerol (85-100%) has been proven in vitro to have similar effects but hasn’t been clinically tested.Objectives: To evaluate the efficacy and tolerability of glycerol (85%) compared to NB-UVB in patients with atopic dermatitis, as assessed by clinical improvement and reduction of staphylococcal colonization of the skin.

ICD-10 classifications
Systemic disorders of connective tissue in diseases classified elsewhereSystemic disorders of connective tissue in other diseases classified elsewhereDiseases of the skin and subcutaneous tissueOther disorders of skin and subcutaneous tissue in diseases classified elsewhereOther disorders of the skin and subcutaneous tissue
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR201810815694251
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR201810815694251 through Pure Global AI's free database. This Not Applicable trial is sponsored by Cairo University and is currently Completed. The study focuses on Skin and Connective Tissue Diseases.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.